0001225208-20-007831.txt : 20200515
0001225208-20-007831.hdr.sgml : 20200515
20200515163459
ACCESSION NUMBER: 0001225208-20-007831
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200513
FILED AS OF DATE: 20200515
DATE AS OF CHANGE: 20200515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobsen Kevin B
CENTRAL INDEX KEY: 0001735465
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07151
FILM NUMBER: 20886022
MAIL ADDRESS:
STREET 1: 1221 BROADWAY
CITY: OAKLAND
STATE: CA
ZIP: 94612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CLOROX CO /DE/
CENTRAL INDEX KEY: 0000021076
STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
IRS NUMBER: 310595760
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: THE CLOROX COMPANY
STREET 2: 1221 BROADWAY
CITY: OAKLAND
STATE: CA
ZIP: 94612-1888
BUSINESS PHONE: 5102717000
MAIL ADDRESS:
STREET 1: P.O. BOX 24305
CITY: OAKLAND
STATE: CA
ZIP: 94612-1305
4
1
doc4.xml
X0306
4
2020-05-13
0000021076
CLOROX CO /DE/
CLX
0001735465
Jacobsen Kevin B
1221 BROADWAY
OAKLAND
CA
94612-1888
1
EVP - Chief Financial Officer
Common Stock
2020-05-13
4
M
0
15630.0000
89.8200
A
21452.0000
D
Common Stock
2020-05-13
4
M
0
3585.0000
84.4500
A
25037.0000
D
Common Stock
2020-05-13
4
S
0
3563.0000
205.4880
D
21474.0000
D
Common Stock
2020-05-13
4
S
0
5419.0000
206.5359
D
16055.0000
D
Common Stock
2020-05-13
4
S
0
6084.0000
207.2839
D
9971.0000
D
Common Stock
40.0000
I
By 401(k)
Common Stock
24.0000
I
By IRA
Common Stock
3145.0000
I
By Trust
Stock Option (Right to Buy)
84.4500
2020-05-13
4
M
0
3585.0000
0.0000
D
2014-09-17
2023-09-17
Common Stock
3585.0000
0.0000
D
Stock Option (Right to Buy)
89.8200
2020-05-13
4
M
0
15630.0000
0.0000
D
2015-09-17
2024-09-17
Common Stock
15630.0000
0.0000
D
Transaction executed pursuant to a pre-planned trading program adopted by reporting person on February 13, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.
This transaction was executed in multiple trades at prices ranging from $204.91 to $205.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $205.94 to $206.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $206.95 to $207.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 84 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
Includes 19 shares acquired through dividend reinvestment during the fiscal year.
By Cheryl Brice, Attorney-in-Fact for
2020-05-15